High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.
Conte PF, Bruzzone M, Carnino F, Gadducci A, Algeri R, Bellini A, Boccardo F, Brunetti I, Catsafados E, Chiara S, Foglia G, Gallo L, Iskra L, Mammoliti S, Parodi G, Ragni N, Rosso R, Rugiati S, Rubagotti A.
Conte PF, et al. Among authors: algeri r.
J Clin Oncol. 1996 Feb;14(2):351-6. doi: 10.1200/JCO.1996.14.2.351.
J Clin Oncol. 1996.
PMID: 8636743
Clinical Trial.